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Résumé en
anglais
Focal amplifications of chromosome 3p13-3p14 occur in about 10% of melanomas
and are associated with a poor prognosis. The melanoma-specific oncogene MITF
resides at the epicentre of this amplicon. However, whether other loci present in this
amplicon also contribute to melanomagenesis is unknown. Here we show that the
recently annotated long non-coding RNA (lncRNA) gene SAMMSON is consistently
co-gained with MITF. In addition, SAMMSON is a target of the lineage-specific
transcription factor SOX10 and its expression is detectable in more than 90% of
human melanomas. Whereas exogenous SAMMSON increases the clonogenic
potential in trans, SAMMSON knockdown drastically decreases the viability of
melanoma cells irrespective of their transcriptional cell state and BRAF, NRAS or
TP53 mutational status. Moreover, SAMMSON targeting sensitizes melanoma to
MAPK-targeting therapeutics both in vitro and in patient-derived xenograft models.
Mechanistically, SAMMSON interacts with p32, a master regulator of mitochondrial
homeostasis and metabolism, to increase its mitochondrial targeting and pro-
oncogenic function. Our results indicate that silencing of the lineage addiction
oncogene SAMMSON disrupts vital mitochondrial functions in a cancer-cell-specific
manner; this silencing is therefore expected to deliver highly effective and tissue-
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